Search

everythinglearnresearchcommunity

for

Search:↓

Talquetamab may cause hair loss and skin issues.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Dupilumab for skin problems might reactivate hair loss in some patients.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

A patient lost all their hair while on rheumatoid arthritis medication.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.